Beam Therapeutics(BEAM) - 2023 Q4 - Annual Report

• publicity concerning our products or competing products and treatments; Even if any of our product candidates we may develop are approved, such products may not achieve an adequate level of acceptance, we may not generate significant product revenues, and we may not become profitable. If, in the future, we are unable to establish sales and marketing capabilities or enter into agreements with third parties to sell and market any product candidates we may develop, we may not be successful in commercializing ...